$DYAI

Dyadic International Inc., DE

  • NASDAQ
  • Biotechnology
  • Health Technology
  • Manufacturing
  • All Other Basic Organic Chemical Manufacturing

PRICE

$3.235 ▲0.466%

Delayed Price

VOLUME

10,018

DAY RANGE

-

52 WEEK

1.74 - 6.89

Join Discuss about DYAI with like-minded investors

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Friday, August 20, 2021 Futures Up/Down % Last Dow -121.00 0.35% 34,697 S&P 500 -16.25 0.36% 4,385 Nasdaq -28.50 0.19% 14,899 Global stock markets are lower again as investors grapple with the spread of the highly contagious COVID-19 delta variant, the impact of the virus on growth and China’s continued crackdown on its technology sector. All eyes on next week’s Federal Reserve’s Jackson Hole symposium where comments on inflation, bond asset purchase tapering will be closely watched. The dollar rose for a fifth day, while Treasury yields continued a slide. Oil prices are currently lower, on track for a 7-day losing streak (longest decline wince 2019) while the U.S. dollar is set for its biggest weekly gain since June (weighing again on commodity prices), currently up at 9 ½ month highs around 93.65 for the dollar index (DXY) with Sept 2020 highs around 94.74. In vaccine news, the Washington Post reported that U.S. health officials are investigating reports that Moderna Inc’s ($MRNA) COVID-19 vaccine may be linked to a higher risk of a rare heart condition in younger adults than previously thought, sending shares lower. In Asian markets, more regulatory concerns/measures crippling stocks as the Nikkei Index slides -267 points (about 1%) to settle at 27,013, the Shanghai Index fell -38 points or 1.1% to close at 3,427 and the Hang Seng Index plunged -466 points or 1.84% to end the week at 24,849. In Europe, the German DAX is down around -70 points (-0.45%) to drop below 15,700, while the FTSE 100 slip about -10 points to 7,045. Stocks finished a choppy Thursday session mixed on concerns the Federal Reserve could begin tapering stimulus this year, even as surging coronavirus infections caused by the delta variant raised worries about the pace of the U.S. recovery. In the bond market, the 10-year Treasury yield at 1.23%. The Russell 2000 SmallCap index pointing to a lower open, entering today with a 6-day losing streak. Market Closing Prices Yesterday The S&P 500 Index climbed 5.53 points, or 0.13%, to 4,405.80 The Dow Jones Industrial Average fell -66.57 points, or 0.19%, to 34,894.12 The Nasdaq Composite gained 15.87 points, or 0.11%, to 14,541.79 The Russell 2000 Index declined -26.36 points, or 1.22% to 2,132.42 Events Calendar for Today 1:00 PM EST Baker Hughes Weekly rig count data Earnings Calendar: Earnings Before the Open: BKE, DE, FL Macro Up/Down Last Nymex -0.47 63.22 Brent -0.48 65.97 Gold 3.70 1,784.10 EUR/USD 0.0006 1.1681 JPY/USD -0.12 109.62 10-Year Note +0.01 1.233% World News Germany July PPI +1.9% MoM vs. +0.8% consensus and rose +10.4% YoY vs. 9.2% consensus UK Jul Retail Sales miss falling -2.5% MoM vs 0.4% consensus and rose +2.4% YoY vs 6.0% consensus; core m/m fell -2.4% vs 0.3% consensus and on a YoY basis, rose +1.8% vs 5.7% consensus Consumer confidence in the U.K. edged down in August but remained at pre-pandemic levels, market-research company GfK said Friday. GfK’s consumer-confidence indicator came in at minus 8 in August, down one point from July vs, forecast an unchanged reading at minus 7. Sector News Breakdown Consumer Farfetch Limited ($FTCH) Q2 EPS loss (-$0.17) vs. est. loss (-$0.33); Q2 revs $523.3M vs. est. $496.8M; Q2 Gross Merchandise Value exceeds $1 billion, up 40% YoY and more than double compared to Q2 2019; full-price sales growth of 90% drives Q2 2021 Digital Platform GMV; Q2 2021 gross profit margin improves by 30 bps year-over-year to 44% Ross Stores ($ROST) 2Q EPS $1.39 vs est. $0.98 on sales $4.8B vs est. $4.5B, comps +15%; sees 3Q comps +5-7% with EPS $0.61-0.69 vs est. $0.93; guides FY EPS $4.20-4.38 vs est. $4.40 on comps +10-11% Macy’s ($M) upgraded to Neutral from Underweight with $25 tgt at JPMorgan Adtalem Global Education Inc. ($ATGE) 4Q adj EPS $0.70 on revs $280.4Mm vs est. $283.4Mm; guides FY22 revs $1.685-1.735B vs est. $1.2B, sees FY22 adj EPS $4.20-4.45 vs est. $3.30 Major League Baseball and the Major League Baseball Players Association have struck new exclusive baseball card agreements with a new company controlled by online sports-merchandise retailer Fanatics Inc., breaking the decades-long grip that Topps Co. ($MUDS) has held on the trading-card market, people familiar with the matter said. https://on.mktw.net/3AX9qSN Tesla ($TSLA) CEO Elon Musk said the electric-vehicle company plans to adapt the artificial intelligence technology it has been developing for autonomous driving to make humanoid robots Energy, Industrials & Materials Deere ($DE) Q3 EPS $5.32 vs. est. $4.58; Q3 revs $11.52B vs. est. $10.3B; full-year earnings forecast raised to range of $5.7B-$5.9B vs. prior guidance of $5.3B-$5.7B; says looking ahead, we expect demand for farm and construction equipment to continue benefiting from favorable fundamentals; sees 2021 production & precision ag net sales up 25 to 30%, 2021 small ag & turf net sales up about 25% Financials Coinbase ($COIN) CEO Brian Armstrong tweeted: “We recently received board approval to purchase over $500M of crypto on our balance sheet to add to our existing holdings. And we’ll be investing 10% of all profit going forward in crypto. I expect this percentage to keep growing over time as the crypto-economy matures. Cboe Global Markets ($CBOE) increases dividend 14% to 48c per share LPL Financial LLC ($LPLA) July total advisory and brokerage assets at the end of July were approximately $1.13 trillion, an increase of $17.6B, or 1.6%, compared to the end of June 2021; total net new assets for July were $10.0B, translating to an 11.5% annualized growth rate The Charles Schwab Corporation ($SCHW) said it is implementing a special five percent pay increase for employees “in recognition of their unwavering service to clients and each other throughout the pandemic Healthcare S. health officials are investigating reports that Moderna Inc’s (MRNA) COVID-19 vaccine may be linked to a higher risk of a rare heart condition in younger adults than previously thought, the Washington Post reported late on Thursday https://reut.rs/3z3wKxP AstraZeneca PLC ($AZN) said Friday it would seek regulatory approval for an antibody drug after a study showed strong efficacy in preventing symptomatic Covid-19, offering a potential new alternative to vaccines for people who refuse shots or for whom they aren’t effective. The company said AZD7442 showed 77% efficacy in reducing risk of symptomatic Covid-19 compared with a placebo in late-stage clinical trials testing its usefulness as a preventive treatment Johnson & Johnson ($JNJ) said that Joaquin Duato, vice chairman of the company’s executive committee, will become CEO on Jan. 3, with Chairman and Chief Executive Alex Gorsky transitioning to executive chairman. Gorsky has served as the company’s chairman and CEO for nearly a decade, and has been with Johnson & Johnson for 30 years. “ Fate Therapeutics ($FATE) announces positive interim clinical data from its FT596 and FT516 off-the-shelf, IPSC-derived NK cell programs for b-cell lymphoma; 10 of 14 Patients in FT596 single-dose escalation cohorts 2 and 3 achieved objective response; 7 patients achieved complete response, including 2 of 3 patients treated with FT596 in combination with Rituximab following autologous CD19 CAR T-cell therapy Sorrento ($SRNE) announces its lead protein-based covid-19 vaccine candidate – dyai-100 – elicits strong neutralizing immune responses in vaccinated animals against sars-cov-2 and multiple major variants of concern Technology, Media & Telecom Applied Materials ($AMAT) 3Q adj EPS $1.90 vs est. $1.77 on revs $6.2B vs est. $5.94B; guides 4Q net sales approx $6.33B +/- $250Mm vs est. $6.04B, sees 4Q adj EPS $1.87-2.01 vs est. $1.81 Adobe Systems ($ADBE) to acquire Io in a transaction, valued at $1.275B Spotify Technology ($SPOT) has authorized to repurchase 10M company’s ordinary shares, up to the amount of $1B Marin Software ($MRIN) enters $50M equity distribution agreement S. listed China shares active amid yet more regulatory pressure headlines; the country approved a strict data privacy law, triggering fresh concerns over the intensity of Beijing’s recent regulatory crackdowns. The Personal Information Protection Law was passed at a meeting in Beijing of the nation’s top legislative body, the Standing Committee of the National People’s Congress. Apple ($AAPL) delays office return to at least January on Covid rise, while IBM closes New York City offices amid rising covid-19 cases A new round of proposed regulations sent Alibaba Group Holding Ltd. ’s ($BABA)S. listing to decline 4.9% on Tuesday to $173.73, its lowest close since October 2019. The Chinese tech company’s American depository receipts have fallen more than 25% so far this year. New draft guidelines released Tuesday by China’s top market regulator aim to prevent internet companies from adopting forced exclusivity and blocking competitors’ links and apps

43 Replies 12 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

should have shorted $DYAI too

124 Replies 10 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

I think $DYAI could get interesting if volume comes in

126 Replies 13 👍 11 🔥

WI
@WINTERTRADE #StockTraders.NET
recently

naov and dyai

105 Replies 14 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

$DYAI might have a trade in it soon... maybe tomorrow

136 Replies 11 👍 7 🔥

profile
@TraderXx #StockTraders.NET
recently

$DYAI keeps reclaiming that 4.80 area, which indicates they are boxing in shorts without them even knowing it

97 Replies 12 👍 10 🔥

profile
@dros #droscrew
recently

RECAP 8/13 +Pos Comments: $GDRX + RayJay $PFE + CFRA $AMD + IBD $HEPS $BLND $YMM + Tipranks $BBVA + Berenberg $DYAI + Zacks RECAP 8/13 -Neg Comments: $MS - Seaport

124 Replies 14 👍 9 🔥

AN
@andres168 #StockTraders.NET
recently

$wish $clov $pltr $dyai

72 Replies 13 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

probably pulls a $DYAI

54 Replies 11 👍 10 🔥

profile
@Chano #StockTraders.NET
recently

$DYAI slap to VWAP

144 Replies 9 👍 14 🔥

profile
@Chano #StockTraders.NET
recently

me too! I paid for locates, I was waiting for something move powerful above 5 to start but nothing > @maletone said: damn, was hoping they would hold up $DYAI and gety it above $5

42 Replies 7 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

damn, was hoping they would hold up $DYAI and gety it above $5

120 Replies 8 👍 12 🔥

profile
@Chano #StockTraders.NET
recently

$DYAI coming to $5

72 Replies 12 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

$DYAI pushing

100 Replies 8 👍 10 🔥

GO
@goodname #StockTraders.NET
recently

Where did you short $DYAI?

41 Replies 12 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

slow day for me only $DYAI short

60 Replies 11 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

$DYAI earnings call tomorrow

118 Replies 13 👍 7 🔥

AN
@andres168 #StockTraders.NET
recently

I'm just watching it $dyai

68 Replies 14 👍 14 🔥

profile
@Chano #StockTraders.NET
recently

chaaaaarge!! > @Math said: shorted some $DYAI

101 Replies 13 👍 7 🔥

profile
@Math #StockTraders.NET
recently

shorted some $DYAI

120 Replies 15 👍 7 🔥

profile
@Chano #StockTraders.NET
recently

action above 5.06s on $DYAI from the last 40 min or so look like a fbo to me

144 Replies 13 👍 7 🔥

SO
@soheil.n #StockTraders.NET
recently

$DYAI - toying with long/shorts...will long once 5 firms up

85 Replies 10 👍 9 🔥

profile
@Math #StockTraders.NET
recently

$DYAI hehe nice long again here

114 Replies 11 👍 12 🔥

AN
@andres168 #StockTraders.NET
recently

$dyai bounce again

147 Replies 14 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

rehit the $DYAI

63 Replies 6 👍 10 🔥

profile
@Math #StockTraders.NET
recently

$DYAI news is decent I said it earlier

47 Replies 8 👍 14 🔥

profile
@Math #StockTraders.NET
recently

$DYAI be sure to have a plan if vwap reclaims

130 Replies 11 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

need $4.50's $4.60 to give out on $DYAI for further fade

125 Replies 13 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

added to $DYAI shot on the pop in 4.80s not much though

121 Replies 9 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

$DYAI another push

118 Replies 9 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

I'm so glad $DYAI gave us another opportunity was sad about my covers on $ORPH

145 Replies 14 👍 6 🔥

GO
@goodname #StockTraders.NET
recently

if it cracks, do you ss right away or wait for a bounce? > @maletone said: just waiting on $DYAI to crack vwap

139 Replies 6 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

just waiting on $DYAI to crack vwap

108 Replies 9 👍 8 🔥

profile
@Chano #StockTraders.NET
recently

starter $DYAI

123 Replies 7 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

lets focus on $DYAI

99 Replies 13 👍 13 🔥

profile
@Chano #StockTraders.NET
recently

damn! DYAI kicked me out! my only trade and a red one

60 Replies 13 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

Covered my last bit of $DYAI

54 Replies 13 👍 9 🔥

profile
@Math #StockTraders.NET
recently

$DYAI news is decent and ETB

51 Replies 8 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

just watching $DYAI & $ORPH

113 Replies 8 👍 12 🔥

AN
@andres168 #StockTraders.NET
recently

covered dyai and sold mrna

77 Replies 14 👍 14 🔥

WI
@WINTERTRADE #StockTraders.NET
recently

nice entry on $dyai @male

115 Replies 14 👍 7 🔥

profile
@TraderXx #StockTraders.NET
recently

@maletone hope you still holding $DYAI short

96 Replies 7 👍 8 🔥

profile
@TraderXx #StockTraders.NET
recently

$DYAi 5 blvd

111 Replies 11 👍 12 🔥

AN
@andres168 #StockTraders.NET
recently

$dyai getting interesting

91 Replies 7 👍 9 🔥

SO
@soheil.n #StockTraders.NET
recently

watchlist: $MRNA , $ZEV, $FSR, $DYAI

88 Replies 10 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

$ZEV, $DYai, $GTIM on watch for me

48 Replies 6 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

watch list for tomorrow: $NNVC, $BVXV, $INTZ, $XBIO, $DYAI add: $SPRT to the list

72 Replies 8 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

watch list for tomorrow: $nnvc, $bvxv, $INTZ, $xbio, $DYAI

62 Replies 9 👍 10 🔥

profile
@Chano #StockTraders.NET
recently

that sucks man! and on the trades that I finally pull the trigger I get smoked, that increases my fears > @soheil.n said: same with DYAI...you're not alone @Chano on the fears of being on the wrong side...i have to get over it as well ...work in progerss

114 Replies 12 👍 11 🔥

SO
@soheil.n #StockTraders.NET
recently

same with DYAI...you're not alone @Chano on the fears of being on the wrong side...i have to get over it as well ...work in progerss

86 Replies 12 👍 8 🔥

Key Metrics

Market Cap

91.01 M

Beta

0

Avg. Volume

29.96 K

Shares Outstanding

28.26 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-11

Next Dividend Date

Company Information

Dyadic International, Inc. is a global biotechnology company which is developing what it believes will be a potentially significant biopharmaceutical gene expression platform based on the fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila), named C1. The C1 microorganism, which enables the development and large-scale manufacture of low-cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales. Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles (VLPs) and antigens, monoclonal antibodies, Fab antibody fragments, Fc-Fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins. Certain other research activities are ongoing which include the exploration of using C1 to develop and produce certain metabolites and other biologic products. Dyadic pursues research and development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to leverage the value and benefits of these technologies in development and manufacture of biopharmaceuticals. As the aging population grows in developed and undeveloped countries, Dyadic believes the C1 technology may help bring biologic vaccines, drugs, and other biologic products to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers, and improve access and cost to patients and the healthcare system, but most importantly save lives.

Website:

HQ: ,

Related News